Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the stock.

Milestone Scientific Stock Performance

MLSS opened at $1.01 on Friday. The firm has a market cap of $78.67 million, a P/E ratio of -14.43 and a beta of 1.41. Milestone Scientific has a fifty-two week low of $0.54 and a fifty-two week high of $1.39. The firm has a 50-day moving average of $1.11 and a 200 day moving average of $0.96.

Hedge Funds Weigh In On Milestone Scientific

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Carnegie Investment Counsel boosted its position in Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares during the period. Geode Capital Management LLC boosted its position in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the period. Y Intercept Hong Kong Ltd bought a new position in Milestone Scientific during the third quarter worth about $48,000. Renaissance Technologies LLC boosted its position in Milestone Scientific by 72.8% during the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after purchasing an additional 53,198 shares during the period. Finally, World Investment Advisors LLC bought a new position in Milestone Scientific during the third quarter worth about $91,000. Institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.